WHO flies to the rescue of a ‘second zone’ vaccine

Spread the love

AstraZeneca, which has developed a vaccine against Covid-19, jointly with the University of Oxford, on Thursday announced a doubling of its profit in 2020 to $ 3.2 billion. However, its action fell, closing at 72.4 pounds (89.1 Swiss francs) on the London Stock Exchange. Over a year, she has lost nearly 4 pounds, not without having hit a peak of 93.2 pounds on July 21, 2020. Suffice to say that doubts about the effectiveness of her vaccine against Covid-19 expressed in recent weeks have darkened somewhat its outlook.

Also read: Ineffective against variant B.1.351, AstraZeneca vaccine suspended in South Africa